More importantly, although conventional chemotherapeutic agents such as paclitaxel and doxorubicin can induce the enrichment of cancer stem cells, knockdown of GABRP reverses this effect, suggesting that GABRP is one of the key mediators of chemotherapy resistance. Here, GABRP is linked to cancer.